Rise of Infections at Healthcare Facilities

by Abby McVay | Sep 23, 2021 | Compliance, Consulting Group, COVID-19, FDA, Healthcare, ISO, Quality, Quality Systems, Regulatory

COVID-19 Fraudulent Products

‌

Health officials have noted that rates of infection have decreased at healthcare facilities before the pandemic. During the pandemic, officials have reported that infections have in fact risen at hospitals and other healthcare facilities.

Looking at data that was collected from the National Healthcare Safety Network, researchers observed infections during every quarter. Researchers also compared every quarter of 2020 to 2019. 2021 data is not yet available for analyzing the report indicated.¹

The researchers noticed that the largest increase in infections was central line infections. Central line infections are associated when catheters are inserted into blood vessels that help provide fluids and even medicine over long periods. In the third and fourth quarters, central line infections were about 47% higher compared to the same time in 2019.¹

Additionally, in the fourth quarter, ventilator-associated infections rose 45% compared to the same time in 2019. More patients are requiring longer hospital visits, which are calling for longer use of medical equipment, like ventilators and catheters.¹

Researchers did report that there was not an increase in surgical-site infections and C. Diff and staph infections. Clostridioides Difficile is a bacterial infection that only happens after a patient is administered antibiotics. Experts agree that the no change in infections is due to a heightened awareness of cleanliness and hygiene as well as a decrease in surgical operations performed.¹

The report concluded that a rise in infections in 2020 is due to employment shortage, longer hospital visits, a higher volume of patients, and supply challenges during the pandemic.¹

EMMA International has been staying on top of all the breaking COVID-19 and FDA news. Contact us at 248-987-4497 or email info@emmainternational.com to get connected with our team of experts today!

¹Mensik, H. (2021, September 2). Pandemic spurs rise of other infections contracted at healthcare facilities. MedTech Dive. https://www.medtechdive.com/news/pandemic-spurs-rise-of-other-infections-contracted-at-healthcare-facilities/606009/

Abby McVay

Abby McVay

Research Analyst- Ms. McVay is EMMA International’s Research Analyst. She has experience in technical writing and clinical trials in many life science industries. She has experience with many different elements of quality and regulatory compliance. Ms. McVay holds a Bachelor of Science in Psychology from Manchester University as well as a Master of Science in Industrial and Organizational Psychology from Angelo State University.

More Resources

Change Management And Control

Change Management And Control

One of the biggest and most important aspects of quality management is a system to monitor changes and how they impact the product. Change management is an approach for changing processes or products in a way which adheres to regulatory standards by ensuring stability and consistency throughout processes. It applies across all changes within a process and throughout an entire products life cycle.

Aseptic Technique and Gowning

Aseptic Technique and Gowning

One of the most common techniques to prevent contamination of products and reduce quality impacts in the pharmaceutical industry is called aseptic gowning. Humans are the biggest sources of microbial contamination in cleanroom environments and therefore proper gowning procedures are essential to ensuring product quality. Proper training, education, hygiene, qualification, and authorization must be put in place and be required for entry to all clean room environments...

Importance of Pharmaceutical GMP

Importance of Pharmaceutical GMP

Having high quality standards is vital to any organization but is even more essential in the pharmaceutical industry. Practices that are governed by these standards are commonly called Good Manufacturing Practices (GMP) and ensure consistent and controlled production of products. These practices govern all aspects and procedures within production and provide documented proof that procedures are consistently followed during the manufacturing processes every time products are made. They are designed to minimize risks throughout the manufacturing process that are not able to be eliminated in final product testing so that pharmaceuticals are safe for use...

See All Resources

Ready to learn more about working with us?

Diverse businesspeople gathered together for negotiations lead by african businesswoman

Pin It on Pinterest

Share This